Eyevensys scientific team has successfully completed a challenging 2-prong development.
1) In collaboration with Nature Technology Inc., Eyevensys developed a high expression plasmid devoid of any antibiotic selection genes.
2) In collaboration with various engineering and design groups, Eyevensys developed an Electro-Transfection Injection System (ETIS) consisting of a device and a pulse generator.
ETIS allows a pinpoint accurate injection of a plasmid into the ciliary muscle and the application of a safe electrical sequence to induce a successful transfection of the plasmid into the ciliary muscle cells. This results in a highly reproducible, dose-dependent, long-lasting protein expression in the eye.